JAMA. 2007 Jan 10;297(2):205-8.

A new era of unapproved drugs: the case of Abigail Alliance v Von Eschenbach.

Source

Center for Law, Ethics, and Health, University of Michigan School of Public Health, Ann Arbor 48109-2029, USA. pdj@umich.edu

PMID:: 17213404; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Drugs, Investigational

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Related citations

Constitutional law--substantive due process--en banc D.C. Circuit rejects fundamental right to experimental medications.--Abigail Alliance for Better Access to Developmental Drugs v. von Eschenbach, 495 F.3d 695 (D.C. Cir. 2007)(en banc), cert. denied, 128 S. Ct. 1069 (2008). [Harv Law Rev. 2008]
Constitutional law--substantive due process--en banc D.C. Circuit rejects fundamental right to experimental medications.--Abigail Alliance for Better Access to Developmental Drugs v. von Eschenbach, 495 F.3d 695 (D.C. Cir. 2007)(en banc), cert. denied, 128 S. Ct. 1069 (2008).
. Harv Law Rev. 2008 Apr; 121(6):1685-92.
Abigail Alliance v. Von Eschenbach: restricting access to potentially lifesaving drugs singe 2007. [J Contemp Health Law Policy. 2008]
Abigail Alliance v. Von Eschenbach: restricting access to potentially lifesaving drugs singe 2007.
Goodman AJ. J Contemp Health Law Policy. 2008 Fall; 25(1):107-41.
A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill. [Seton Hall Law Rev. 2009]
A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
Ochs A. Seton Hall Law Rev. 2009; 39(2):559-603.
Review Expanding access to investigational new therapies. [Prim Care. 1992]
Review Expanding access to investigational new therapies.
Cohen C, Shevitz A, Mayer K. Prim Care. 1992 Mar; 19(1):87-96.
Review Mechanics of the Food and Drug Administration's Form 1571: investigational new drug application. [Retina. 2005]
Review Mechanics of the Food and Drug Administration's Form 1571: investigational new drug application.
Novack G. Retina. 2005 Dec; 25(8 Suppl):S96-S97.

See reviews... See all...

Cited by 2 PubMed Central articles

Scientific research and the public trust. [Sci Eng Ethics. 2011]
Scientific research and the public trust.
Resnik DB. Sci Eng Ethics. 2011 Sep; 17(3):399-409. Epub 2010 Aug 29.
Preemption, tort reform, and pharmaceutical claims: Part two: Has the Food and Drug Administration shown it is solely responsible for the protection of patients? Can it do so? Will it do so? [Proc (Bayl Univ Med Cent). 2008]
Preemption, tort reform, and pharmaceutical claims: Part two: Has the Food and Drug Administration shown it is solely responsible for the protection of patients? Can it do so? Will it do so?
Thornton RG. Proc (Bayl Univ Med Cent). 2008 Jan; 21(1):82-92.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A new era of unapproved drugs: the case of Abigail Alliance v Von Eschenbach.
A new era of unapproved drugs: the case of Abigail Alliance v Von Eschenbach.
JAMA. 2007 Jan 10 ;297(2):205-8.

PubMed
Litigating the science of breast cancer treatment.
Litigating the science of breast cancer treatment.
J Health Polit Policy Law. 2007 Oct ;32(5):785-818.

PubMed
Legal challenges to managed care cost containment programs: an initial assessmen...
Legal challenges to managed care cost containment programs: an initial assessment.
Health Aff (Millwood). 1999 Jul-Aug ;18(4):69-85.

PubMed
Cost-effectiveness analysis in the courts: recent trends and future prospects.
Cost-effectiveness analysis in the courts: recent trends and future prospects.
J Health Polit Policy Law. 2001 Apr ;26(2):291-326.

PubMed
ERISA litigation and physician autonomy.
ERISA litigation and physician autonomy.
JAMA. 2000 Feb 16 ;283(7):921-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

A new era of unapproved drugs: the case of Abigail Alliance v Von Eschenbach.

Source

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Related citations

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information